Filing Details

Accession Number:
0001209191-15-009486
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-04 16:59:42
Reporting Period:
2015-02-03
Filing Date:
2015-02-04
Accepted Time:
2015-02-04 16:59:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Perkinelmer Inc PKI Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224110 F Robert Friel 940 Winter Street
Waltham MA 02451
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-02-03 60,709 $12.95 593,019 No 4 M Direct
Common Stock Disposition 2015-02-03 60,709 $46.26 532,310 No 4 S Direct
Common Stock Acquisiton 2015-02-03 36,835 $0.00 569,145 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock NQ Stock Option (right to buy) Disposition 2015-02-03 60,709 $0.00 60,709 $12.95
Common Stock NQ Stock Option (right to buy) Acquisiton 2015-02-03 156,818 $0.00 156,818 $46.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-02-03 No 4 M Direct
156,818 2022-02-03 No 4 A Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Friel on December 4, 2014.
  2. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $45.710 to $46.490. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. Shares are time-based restricted stock that will vest in full on the third anniversary of the date of grant.
  4. This option became exercisable in three equal annual installments beginning on February 3, 2010, which was the first anniversary of the date on which the option was granted.
  5. This option vests in three equal annual installments beginning on the first anniversary of the date of grant, and has a 7 year exercise term.